ANti-Oxidant in Variant Angina (ANOVA) Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 320 participants.

Also called NCT03228238

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 320 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03228238
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03228238. Randomized; no masking; primary purpose treatment. Start 2014-09-01 (actual); primary completion 2024-06-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ANti-Oxidant in Variant Angina (ANOVA) Trial
Condition
Variant Angina
Intervention (Drug)
Vitamin C and Vitamin E
Intervention (Drug)
Statin
Intervention (Drug)
Standard medication for variant angina
Lead sponsor
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct03228238
Content hash
9e19f9a18cd8d3babc49f5f1f60f88ae1f68c2539c77ed2c718a6517e6efe9b7